Anti-tumor effectiveness of a novel bispecific antibody that blocks both PD-L1 and LAG-3

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 93ba08e0df22cfb0-LAX IP: 47.97.18.252 UTC time: 2025-05-06T17:00:35+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

Comments (0)

No login
gif